Patent details

EP2386294 Title: Unitary pharmaceutical dosage form comprising Tenofovir DF

Basic Information

Publication number:
EP2386294
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP111671012
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Unitary pharmaceutical dosage form comprising Tenofovir DF
French Title of Invention:
Forme unitaire pharmaceutique contenant du tenofovir DF
German Title of Invention:
Einheitliche pharmazeutische Dosierungsform enthaltend Tenofovir DF
SPC Number:

Dates

Filing date:
13/06/2006
Grant date:
04/03/2015
EP Publication Date:
04/03/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/11/2011
EP B1 Publication Date:
04/03/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
13/06/2026
Renunciation date:
Revocation date:
13/01/2022
Annulment date:

Owner

From:
09/02/2018
 
 

Name:
Gilead Sciences, LLC
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

History of Owners

From:
13/06/2006
To:
09/02/2018

Name:
Bristol-Myers Squibb & Gilead Sciences LLC
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
22/04/2015
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
Menning Mark, M.
Address:
United States (US)

2

Name:
Hussain Munir, A.
Address:
United States (US)

3

Name:
Yang Taiyin
Address:
United States (US)

4

Name:
Oliyai Reza
Address:
United States (US)

5

Name:
Lipper Robert, A.
Address:
United States (US)

6

Name:
Jerzewski Robert, L.
Address:
United States (US)

7

Name:
Dahl Terrence, C.
Address:
United States (US)

Priority

1

Priority Number:
690010 P
Priority Date:
13/06/2005
Priority Country:
United States (US)

2

Priority Number:
771279 P
Priority Date:
07/02/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/24;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2022/08
Publication date:
01/07/2022
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
201811
Publication date:
14/03/2018
Description:
Transfer of Rights

2

Issue number:
201818
Publication date:
02/05/2018
Description:
Title of invention Modified

3

Issue number:
202224
Publication date:
15/06/2022
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/05/2022
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56